Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis

Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder

(2016) Walter Deberdt   Therapeutics and Clinical Risk Management

Metformin for Weight Control in Pediatric Patients on Atypical Antipsychotic Medication

(2009) Lauren Shin et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial

(2009) T. Baptista et al.   PHARMACOPSYCHIATRY

Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription

(2009) Y. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study

(2009) Edgardo Carrizo et al.   SCHIZOPHRENIA RESEARCH

Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study

(2008) Ren-Rong Wu et al.   AMERICAN JOURNAL OF PSYCHIATRY

Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain

(2008) Ren-Rong Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study

(2008) Trino Baptista et al.   PSYCHIATRY RESEARCH

Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine

(2007) Chun-Hsin Chen et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY